Почетна › Trostruko negativni rak dojke › Kalifornija › Los Angeles
Kliničke studije za Trostruko negativni rak dojke u gradu Los Angeles, CA
27 studija za Trostruko negativni rak dojke traži učesnike na lokacijama u gradu Los Angeles i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Тражи се учесникФаза 3
- UCLA Department of Medicine - Hematology & Oncology ( Site 0047), Los Angeles
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
Тражи се учесникФаза 1
- The Angeles Clinic and Research Institute (TACRI), Los Angeles
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1
- University of California - Los Angeles, Los Angeles
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Тражи се учесникФаза 1
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Тражи се учесникФаза 3
- Cedars-Sinai Cancer at Beverly Hills, Los Angeles
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Тражи се учесникФаза 1/2
- University of California Los Angeles Medical Center, Los Angeles
Study of XB010 in Subjects With Solid Tumors
Тражи се учесникФаза 1
- UCLA Department of Medicine - Hematology/Oncology, Los Angeles
Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer and HR+/HER2- Metastatic Breast Cancer
Тражи се учесникФаза 1/2
- Cedars-Sinai Medical Center, Los Angeles
Intratumoral N17350 in Advanced Solid Tumors
Тражи се учесникФаза 1/2
- The Angeles Clinic and Research Institute, Los Angeles
- UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
SMP-3124LP in Adults With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Cedars Sinai Medical Center, Los Angeles
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients
Тражи се учесникФаза 2
- Ellison Institute of Technology (EITM), Los Angeles
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- USC/Norris Comprehensive Cancer Center, Los Angeles
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Тражи се учесникФаза 2/3
- USC/Norris Comprehensive Cancer Center, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer
Тражи се учесникФаза 2
- Cedars-Sinai Medical Center, Los Angeles
- Cedars-Sinai Medical Center Beverly Hills, Los Angeles
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Тражи се учесникФаза 1
- University of California LA, Los Angeles
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Тражи се учесникФаза 1
- USC Norris Comprehensive Cancer Center /ID# 279603, Los Angeles
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Тражи се учесникФаза 1
- Start Lacn, Los Angeles
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
Тражи се учесникФаза 1
- USC / Norris Comprehensive Cancer Center, Los Angeles
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Тражи се учесникФаза 2
- University of Southern California, Los Angeles
Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
Тражи се учесникФаза 2
- Cedars-Sinai Medical Center, Los Angeles
Access to Genetic Testing in Underserved Patients With Cancer
Тражи се учесникЗдраве особе су добродошле
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
Тражи се учесникФаза 1/2
- Los Angeles Cancer Network (LACN) - Good Sam, Los Angeles
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Тражи се учесникФаза 1/2
- University of Southern California, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
Тражи се учесникФаза 1
- University of Southern California, Los Angeles
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Тражи се учесникФаза 1/2
- UCLA Medical Center, Los Angeles
Studije za Trostruko negativni rak dojke u drugim gradovima
- Houston, TX42 студија
- New York City, NY33 студија
- Nashville, TN28 студија
- Boston, MA24 студија
- San Antonio, TX24 студија
- Arlington, VA21 студија
- St. Louis, MO21 студија
- Atlanta, GA19 студија
- Dallas, TX18 студија
- New Haven, CT16 студија
- Grand Rapids, MI16 студија
- Chicago, IL16 студија
Ostale studije u gradu Los Angeles
- Немалоклетни карцином плућа92 студија
- Рак дојке73 студија
- Рак (све врсте)73 студија
- Рак простате64 студија
- Колоректални карцином61 студија
- Метастатски карцином57 студија
- Рак јајника53 студија
- Рак плућа45 студија
- Плоскоклеточни карцином главе и врата43 студија
- Рак панкреаса36 студија
- Карцином ендометријума35 студија
- Меланом34 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.